Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Free Cash Flow: 2023-2025

Historic Free Cash Flow for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to -$177,000.

  • BioLineRx's Free Cash Flow rose 98.43% to -$177,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$21.3 million, marking a year-over-year increase of 30.12%. This contributed to the annual value of -$43.9 million for FY2024, which is 93.30% down from last year.
  • As of Q2 2025, BioLineRx's Free Cash Flow stood at -$177,000, which was up 93.17% from -$2.6 million recorded in Q1 2025.
  • In the past 5 years, BioLineRx's Free Cash Flow registered a high of $4.8 million during Q4 2023, and its lowest value of -$14.1 million during Q1 2024.
  • For the 3-year period, BioLineRx's Free Cash Flow averaged around -$6.9 million, with its median value being -$9.2 million (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 282.66% in 2024, then spiked by 98.43% in 2025.
  • Over the past 3 years, BioLineRx's Free Cash Flow (Quarterly) stood at $4.8 million in 2023, then slumped by 282.66% to -$8.7 million in 2024, then skyrocketed by 98.43% to -$177,000 in 2025.
  • Its last three reported values are -$177,000 in Q2 2025, -$2.6 million for Q1 2025, and -$8.7 million during Q4 2024.